YOUR PAMA PARTNER
EvidenceCare streamlines consulting Appropriate Use Criteria (AUC) for advanced imaging so that providers can meet requirements under the Protecting Access to Medicare Act (PAMA).
Adhering to AUC consultation requirements shouldn’t interrupt a provider’s workflow.
Providers rely on EvidenceCare to deliver the most complete and relevant clinical content to providers precisely when they need it most. Referencing Appropriate Use Criteria for advanced imaging studies is no exception. EvidenceCare connects seamlessly within the provider’s workflow to provide immediate consultation based on the care decisions made on behalf of the patient. And, as a CMS-qualified Clinical Decision Support Mechanism (qCDSM), providers and their health systems have assurance they are fully compliant with this important federal mandate.
EvidenceCare provides access to advanced imaging guidelines for all care settings, including hospital emergency and outpatient departments, physician offices, ambulatory surgical centers, and independent diagnostic testing facilities. Accessed at the time of order, EvidenceCare delivers real-time information so your providers can focus on delivering the best care possible for your patients.
How it works.
Clinical Need for Imaging
Throughout the course of care, a provider identifies the need for advanced imaging to determine the appropriate diagnosis and treatment for a patient.
Launch AUC Protocol
At the point of ordering the imaging, the provider launches an EvidenceCare AUC protocol and answers a few quick questions about the patient’s presentation, history, and condition.
Consultation for Appropriate Use
EvidenceCare consults the correct AUC guidelines to determine the appropriateness of the imaging study selected for the patient. Approval or denial is provided, and the authorization code, when applicable, is notated in the record.
EvidenceCare has partnered with Intermountain Healthcare to deploy their evidence-based standards for imaging. Intermountain Healthcare is certified by CMS as a qualified Provider Led Entity (PLE) authorized to produce advanced imaging AUC.